Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California
blank

 

Recent News and Articles on the Keywords: liver cancer + molecule blocks + cancer  Related to the article below (Last Update: 5/12/2008)

5 New Drugs Revealed -- for Cancer, Blood Clots, Diabetes, and ...
Wired News - Apr 16, 2008
Bristol-Myers Squibb has concocted a drug that works by blocking androgen receptors on prostate cancer cells. In the absence of that hormonal message, ...
Rosetta Genomics: Mining Genes From Junk (Part II)
Seeking Alpha, NY - Apr 14, 2008
In addition, in 2009 Rosetta expects to become a clinical stage company after the IND filing for a liver cancer drug which is being co-developed with Isis ...ROSG
Source: Google News

The phosphatidylinositol 3-Kinase?AKT pathway in human cancer -
I Vivanco, CL Sawyers - Nature Reviews Cancer, 2002 - computableplant.ics.uci.edu
... Small- molecule therapeutics that block PI3K signalling might deal a severe blow
to cancer cells by blocking many aspects of the tumour-cell phenotype. ...

[PDF] Angiogenesis in cancer and other diseases -
P Carmeliet, RK Jain - Nature, 2000 - cmbi.bjmu.edu.cn
... and overcome the pressure barrier to the deliveryof molecular medicine in ... vessels
enlarge and become tortuous) epithelia liver regeneration, cancer ...
-

… glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and … -
TM Block, MA Comunale, M Lowman, LF Steel, PR … - Proceedings of the National Academy of Sciences, 2005 - National Acad Sciences
... to be hyperfucosylated in human liver cancer (20, 39 ... work was supported by the National
Cancer Institute Innovative Molecular Analysis Technologies ...

[PDF] Papillomaviruses and cancer: from basic studies to clinical application -
H zur Hausen - Nature Reviews Cancer, 2002 - mcdb.colorado.edu
... in malig- nant tissue, and inhibiting their expression blocks the malignant ... In the
course of cancer development, the viral molecule frequently becomes ...
-

[PDF] NEW FUNCTIONS FOR THE MATRIX METALLOPROTEINASES IN CANCER PROGRESSION -
M Egeblad, Z Werb - Nature Reviews Cancer, 2002 - microarray.princeton.edu
... Whether MMP activity is required for generating antitumour molecules such as
pro-apoptotic ... MMPs are just markers of differen- tiation of the cancer cells or of ...
-

The STATs of cancer?new molecular targets come of age -
H Yu, R Jove - Nat Rev Cancer, 2004 - devcell.bio.uci.edu
... clearly a genetic disease 1?3 , the best molecular targets for cancer therapy are ...
5 . Targeting a single transcription factor can block the effects ...

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-?B -
AS Baldwin - Journal of Clinical Investigation, 2001 - pubmedcentral.nih.gov
... First, small molecule inhibitors of the stress ... Using rat liver epithelial cells,
Sonenshein and ... in a significant proportion of breast cancer, stimulates the ...

Molecular viral oncology of hepatocellular carcinoma -
TM Block, AS Mehta, CJ Fimmel, R Jordan - Oncogene, 2003 - nature.com
... which is also a predisposition for liver cancer. ... pathogenesis of HBV-associated liver
disease in ... defensively to foreign pathogen molecules without assistance ...

TNF-and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-kappa B -
CY Wang, MW Mayo, AS Baldwin Jr - Science, 1996 - sciencemag.org
... Curriculum in Genetics and Molecular Biology, and ... be addressed at Lineberger
Comprehensive Cancer Center, Campus ... extensive apoptosis within the liver (2). Many ...

Involvement of chemokine receptors in breast cancer metastasis -
A M?ller, B Homey, H Soto, N Ge, D Catron, ME … - Nature, 2001 - nature.com
... Proteins from homogenized normal human lung, liver, skin and ... Yeatman, TJ & Nicolson,
GL Molecular basis of ... J. Patterns of recurrent disease in breast cancer. ...

Source: Google Scholar

MOLECULE BLOCKS GENE, SHEDS LIGHT ON LIVER CANCER

COLUMBUS , Ohio – New research shows how a particular small molecule blocks the activity of a cancer-suppressing gene, allowing liver-cancer cells to grow and spread.

This molecule is a microRNA, a recently discovered class of tiny molecules used by cells to help control the kinds and amounts of proteins they make. More than 250 different microRNAs have been discovered, and several have been linked to cancer.

These findings show exactly how one specific microRNA, called miR-21, helps cancer develop.

This molecule occurs at unusually high levels in many kinds of cancer cells. The study looked at a gene called PTEN (pronounced P-TEN), which normally protects cells from becoming cancerous. Researchers know that the abnormal silencing of this tumor-suppressor gene contributes to the development of liver cancer and other malignancies.

The researchers showed that adding high levels of miR-21 to normal liver cells caused PTEN levels to drop. They also traced the chemical pathways that increased the cells' abilities to proliferate, migrate and invade other tissues.

The findings help explain how liver cancer develops and may identify new drug targets for treating the disease. This particular microRNA might also provide a marker to help determine a patient's prognosis.

The study, led by researchers at the Ohio State University Comprehensive Cancer Center, is published in the August issue of the journal Gastroenterology.

“Our findings essentially describe a new mechanism used by cells to regulate PTEN,” says principal investigator Tushar Patel, professor of internal medicine, director of hepatology and a liver-cancer specialist at Ohio State University Medical Center.

They show that high levels of miR-21 block the PTEN gene, he explained. This, in turn, activates chemical pathways that enable cancer cells to proliferate, migrate and invade other tissues, all of which are features of tumor formation.

Patel and his collaborators began the study by measuring the relative levels of 197 microRNAs in normal liver cells and in liver cancer cells from human tumors and in four liver cancer cell lines.

Levels of miR-21 were up to nine times greater in liver-tumor tissue compared with normal liver tissue, twice that of the next highest microRNA.

Earlier research led by Patel had shown that miR-21 probably targeted PTEN, and this study confirmed that.

Furthermore, the researchers showed that adding high levels of miR-21 to normal liver cells caused PTEN levels to drop. They also traced the chemical pathways that increased the cells' abilities to proliferate, migrate and invade other tissues.

“Our findings indicate that miR-21 plays a fundamental role in tumor-cell behavior and cancer development,” Patel says, “and this may also be relevant to other tumors in which miR-21 is overexpressed. If this work is reproduced in investigations of other cancers, it could be a big step forward,” he says.

Funding from the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases and the Scott and White Hospital Foundation supported this research.

#

Contact: Eileen Scahill, Medical Center Communications, 614-293-3737, or Eileen.Scahill@osumc.edu
 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.